These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 18832429

  • 1. Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use.
    Bedi G, Van Dam NT, Redman J.
    J Psychopharmacol; 2010 Feb; 24(2):233-40. PubMed ID: 18832429
    [Abstract] [Full Text] [Related]

  • 2. Is emotional intelligence impaired in ecstasy-polydrug users?
    Craig L, Fisk JE, Montgomery C, Murphy PN, Wareing M.
    J Psychopharmacol; 2010 Feb; 24(2):221-31. PubMed ID: 18801831
    [Abstract] [Full Text] [Related]

  • 3. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A.
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [Abstract] [Full Text] [Related]

  • 4. Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms.
    Milani RM, Parrott AC, Schifano F, Turner JJ.
    Hum Psychopharmacol; 2005 Jun; 20(4):249-61. PubMed ID: 15816011
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.
    Soar K, Parrott A, Turner J.
    J Psychopharmacol; 2009 Sep; 23(7):745-58. PubMed ID: 18635698
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Gender differences in self-reported anxiety, depression, and somatization among ecstasy/MDMA polydrug users, alcohol/tobacco users, and nondrug users.
    Milani RM, Parrott AC, Turner JJ, Fox HC.
    Addict Behav; 2004 Jul; 29(5):965-71. PubMed ID: 15219343
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. An investigation of factors associated with depressive symptoms among a sample of regular ecstasy consumers.
    Matthews AJ, Bruno R.
    Neuropsychobiology; 2010 Jul; 61(4):215-22. PubMed ID: 20389132
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Metamemory in recreational ecstasy polydrug users: what do self-reports of memory failures mean?
    Bedi G, Redman J.
    J Psychopharmacol; 2008 Nov; 22(8):872-81. PubMed ID: 18208933
    [Abstract] [Full Text] [Related]

  • 14. Enhanced intensity dependence and aggression history indicate previous regular ecstasy use in abstinent polydrug users.
    Wan L, Baldridge RM, Colby AM, Stanford MS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov 13; 33(8):1484-90. PubMed ID: 19703509
    [Abstract] [Full Text] [Related]

  • 15. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.
    Scholey AB, Parrott AC, Buchanan T, Heffernan TM, Ling J, Rodgers J.
    Addict Behav; 2004 Jun 13; 29(4):743-52. PubMed ID: 15135556
    [Abstract] [Full Text] [Related]

  • 16. An investigation of the subacute effects of ecstasy on neuropsychological performance, sleep and mood in regular ecstasy users.
    Pirona A, Morgan MJ.
    J Psychopharmacol; 2010 Feb 13; 24(2):175-85. PubMed ID: 19351799
    [Abstract] [Full Text] [Related]

  • 17. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
    Indlekofer F, Piechatzek M, Daamen M, Glasmacher C, Lieb R, Pfister H, Tucha O, Lange KW, Wittchen HU, Schütz CG.
    J Psychopharmacol; 2009 Jul 13; 23(5):495-509. PubMed ID: 18635709
    [Abstract] [Full Text] [Related]

  • 18. Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: evidence from an 18 months longitudinal study.
    Daumann J, Till B, Fischermann T, Rezk M, Gouzoulis-Mayfrank E.
    J Psychopharmacol; 2006 Mar 13; 20(2):236-44. PubMed ID: 16510481
    [Abstract] [Full Text] [Related]

  • 19. Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users.
    Parrott AC, Buchanan T, Scholey AB, Heffernan T, Ling J, Rodgers J.
    Hum Psychopharmacol; 2002 Aug 13; 17(6):309-12. PubMed ID: 12404677
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.